ELLIPTA
Showing 1 - 25 of 87
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- (no location specified)
Sep 7, 2022
COPD Trial in Keswick (Anoro Ellipta, Arnuity Ellipta)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Anoro Ellipta
- Arnuity Ellipta
-
Keswick, VirginiaRoselove NUNOO-ASARE
May 3, 2022
Asthma Trial in Enschede, Nijverdal, Rotterdam (ELLIPTA, BREEZHALER)
Completed
- Asthma
- ELLIPTA
- BREEZHALER
-
Enschede, Netherlands
- +2 more
Oct 7, 2021
RELVAR® 100 ELLIPTA® Special Drug Use Investigation
Completed
- Pulmonary Disease, Chronic Obstructive
- RELVAR 100 ELLIPTA
-
Hokkaido, Japan
- +1 more
Jul 26, 2021
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- ELLIPTA
- (no location specified)
Aug 15, 2022
Arnuity® Ellipta® Drug Use Investigation
Completed
- Asthma
- Arnuity Ellipta
-
Hokkaido, Japan
- +1 more
Apr 22, 2021
Copd Trial in Dallas (TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation)
Not yet recruiting
- Copd
- TRELEGY ELLIPTA 100Mcg-62.5Mcg-25Mcg/Actuation Powder for Inhalation
-
Dallas, TexasBaylor Scott & White Health Research Institute
Mar 22, 2022
COPD Trial in Farmington Hills (Trelegy Ellipta 100/62.5/25Mcg Inh 30D, Ventolin 90Mcg/Actuation Inhalation Aerosol)
Completed
- COPD
- Trelegy Ellipta 100/62.5/25Mcg Inh 30D
- Ventolin 90Mcg/Actuation Inhalation Aerosol
-
Farmington Hills, MichiganPulmonary Research Institute of Southeast Michigan
Dec 15, 2021
COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol
Withdrawn
- COPD
- Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
- Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
- (no location specified)
Jan 19, 2022
US Based on Pharmacy and Medical Claims That Compares How Well
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
White Plains, New YorkeMax health
Jan 11, 2022
Using US Medical and Pharmacy Claim Records to Compare Resource
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
Eden Prairie, MinnesotaOptum
Mar 11, 2022
Error Rates Between ELLIPTA® Dry Powder Inhaler and Other DPIs
Completed
- Pulmonary Disease, Chronic Obstructive
- Relvar ELLIPTA
- +6 more
-
Beek En Donk, Netherlands
- +12 more
Oct 6, 2020
COPD Trial in Germany, United Kingdom (AZD8871, Anoro® Ellipta®)
Completed
- Chronic Obstructive Pulmonary Disease
- AZD8871
- Anoro® Ellipta®
-
Berlin, Germany
- +4 more
Nov 24, 2020
Pulmonary Disease, Chronic Obstructive Trial in Canada, Denmark (GSK2269557, Placebo, DISKUS)
Completed
- Pulmonary Disease, Chronic Obstructive
- GSK2269557
- +3 more
-
Vancouver, British Columbia, Canada
- +5 more
Aug 12, 2021
Pharmacokinetics Trial in Copenhagen (Fluticasone Furoate/ Vilanterol Trifenatate)
Completed
- Pharmacokinetics
- Fluticasone Furoate/ Vilanterol Trifenatate
-
Copenhagen, DenmarkRespiratory research unit, Bispebjerg University Hospital
Jan 26, 2021
Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)
Terminated
- Pulmonary Disease, Chronic Obstructive
- Bronchodilator Agents
-
Bari, BA, Italy
- +38 more
Dec 23, 2022
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (Placebo ELLIPTA, Nemiralisib ELLIPTA 50 µg, Nemiralisib ELLIPTA 100
Terminated
- Pulmonary Disease, Chronic Obstructive
- Placebo ELLIPTA
- +7 more
-
Mobile, Alabama
- +161 more
Jul 13, 2021
Pulmonary Disease, Chronic Obstructive Trial in United States (ELLIPTA DPI, DISKUS DPI, HandiHaler DPI)
Completed
- Pulmonary Disease, Chronic Obstructive
- ELLIPTA placebo DPI
- +3 more
-
Orlando, Florida
- +17 more
Jun 26, 2020
Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting
Withdrawn
- Pulmonary Disease, Chronic Obstructive
- Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
- Fluticasone furoate/umeclidinium/vilanterol
-
Waterbury, Connecticut
- +2 more
Apr 21, 2020
Chronic Obstructive Pulmonary Disease Dual Therapy Burden of
Completed
- Pulmonary Disease, Chronic Obstructive
- UMEC/VI
- +5 more
-
Durham, North CarolinaGSK Investigational Site
Jul 20, 2020
Asthma Trial in Worldwide (FF/VI via ELLIPTA DPI, FF via ELLIPTA DPI)
Completed
- Asthma
- FF/VI via ELLIPTA DPI
- FF via ELLIPTA DPI
-
Hoover, Alabama
- +183 more
Sep 12, 2022
COPD Trial in United Kingdom (Tiotropium & olodaterol, fluticasone furoate & vilanterol)
Completed
- Chronic Obstructive Pulmonary Disease
- Tiotropium & olodaterol
- fluticasone furoate & vilanterol
-
Dundee, United Kingdom
- +3 more
Jul 16, 2020